Evidence map›Paper›PMID 17581882›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosis.

Berna S Sayan, A Emre Sayan, Ai Li Yang, Rami I Aqeilan, Eleonora Candi, Gerald M Cohen, Richard A Knight, Carlo M Croce, Gerry Melino

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. STAT3, stem cells, cancer stem cells and p63.Cellular & molecular biology letters · 2018
    Review
  7. Requirement of zinc transporter ZIP10 for epidermal development: Implication of the ZIP10-p63 axis in epithelial homeostasis.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  8. Review
  9. The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System.International journal of molecular sciences · 2016
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. The role of p63 in cancer, stem cells and cancer stem cells.Cellular & molecular biology letters · 2011
    Review
  15. Article
  16. Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  17. Article
  18. Article
  19. Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Berna S Sayan*Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, United Kingdom.
A Emre Sayan
Ai Li Yang
Rami I Aqeilan
Eleonora Candi
Gerald M Cohen
Richard A Knight
Carlo M Croce
Gerry Melino
Medical Research Council · GBThe Ohio State University · USUniversity of Rome Tor Vergata · IT

Funding

Medical Research Council MC_U132615750Medical Research Council MC_U132670600Telethon GGP04110
6 · The paper itself

Abstract

p63 is a p53-related transcription factor. Utilization of two different promoters and alternative splicing at the C terminus lead to generation of six isoforms. The alpha isoforms of TAp63 and DeltaNp63 contain a transactivation-inhibitory (TI) domain at the C termini, which can bind to the transactivation (TA) domain and inhibit its transcriptional activity. Consequently, TAp63alpha can directly inhibit its activity through an intramolecular interaction; similarly, DeltaNp63alpha can inhibit the activity of the active TAp63 isoforms through an intermolecular interaction. In this work, we demonstrate that after induction of apoptosis, the TI domain of the p63alpha isoforms is cleaved by activated caspases. Cleavage of DeltaNp63alpha relieves its inhibitory effect on the transcriptionally active p63 proteins, and the cleavage of TAp63alpha results in production of a TAp63 protein with enhanced transcriptional activity. In agreement with these data, generation of the N-terminal TAp63 fragment has a role in apoptosis because stable cell lines expressing wild-type TAp63 are more sensitive to apoptosis compared with cells expressing the noncleavable mutant. We also used a model system in which TAp63 expression was induced by trichostatin-A treatment in HCT116 cells. Trichostatin-A sensitized these cells to apoptosis, and this sensitization was associated with cleavage of up-regulated p63.

Indexed as

ApoptosisCaspasesCell LineDNA-Binding ProteinsHumansHydrolysisProtein IsoformsProtein Structure, TertiaryTrans-ActivatorsTranscriptional ActivationTranscription FactorsTumor Suppressor ProteinsCaspasesDNA-Binding ProteinsProtein IsoformsTP63 protein, humanTrans-ActivatorsTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID17581882
PMCPMC1904122
OpenAlexW2030272800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.